Noninvasive Cerebrovascular Assessment of Takayasu Arteritis
Stroke 31:2197-2202, Cantu,C. et al, 2000
Family Support for Stroke: a Randomised Controlled Trial
Lancet 356:808-813, Mant,J. et al, 2000
Alternative Strategies for Stroke Care: a Prospective Randomised Controlled Trial
Lancet 356:894-899,869, Kalra,L. et al, 2000
Long-Term Clinical and Angiographic Outcomes in Symptomatic Patients with 70% to 99% Carotid Artery Stenosis
Stroke 31:2037-2042, Paciaroni,M. et al, 2000
Stroke Prevention
Neurol Clin 18:321-341, Wein,T.H. &Bornstein,N.M., 2000
Diffusion-Weighted MR Imaging of the Brain
Radiology 217:331-345, Schaefer,P.W.,et al, 2000
Toxoplasmosis Manifesting as Hydroephalus on Computed Tomography
Infect Dis Clin Practice 9:390-392, Finelli,P.F. &Uphoff,D.F., 2000
Cerebrovascular Ischemic Events in Wind Instrument Players
Neurol 55:865-867, Evers, S. et al, 2000
Whole Grain Consumption and Risk of Ischemic Stroke in Women
JAMA 284:1534-1540, Liu,S. et al, 2000
Periodontal Disease and Risk of Cerebrovascular Disease
Arch Int Med 160:2749-2755, Wu,T.,et al, 2000
Vitamin E and Beta Carotene Supplementation in High Risk for Stroke
Arch Neurol 57:1503-1509, Leppala,J.M.,et al, 2000
New Transient Ischemic Attack and Stroke
Arch Int Med 160:2941-2946, Goldstein,L.B.,et al, 2000
Combined Intravenous and Intra-Arterial Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
Stroke 31:2552-2557, Ernst,R.,et al, 2000
Frequency and Location of Microbleeds in Patients With Primary Intracerebral Hemorrhage
Stroke 31:2665-2669, Roob,G.,et al, 2000
Is Early Ischemic Lesion Volume on Diffusion-Weighted Imaging an Independent Predictor of Stroke Outcome?
Stroke 31:2597-2602, Thijs,V.N.,et al, 2000
Seizures After Stroke
Arch Neurol 57:1617-1622, Bladin,C.F.,et al, 2000
Cardiac Involvement in Patients with Acute Neurologic Disease
Arch Int Med 160:3153-3158, Dixit,S.,et al, 2000
Diffusion-Weighted Imaging of Patients with Subacute Cerebral Ischemia: Comparison with Conventional and Contrast-Enhanced MR Imaging
AJNR 21:1596-1602,1569, Augustin,M.,et al, 2000
Homocysteine and Neurologic Disease
Arch Neurol 57:1422-1428, Diaz-Arrastia,R., 2000
The Association Between the Diameter of a Patent Foramen Ovale and the Risk of Embolic Cerebrovascular Events
Am J Med 109:456-462,506, Schuchlenz,H.W.,et al, 2000
Interatrial Septal Abnormalities and Stroke
Neurol 55:1172-1179, Overell,J.R.,et al, 2000
MRI Findings in Mobius Syndrome: Correlation with Clinical Features
Neurol 55:1058-1060, Pedraza,S.,et al, 2000
Pulmonary Arteriovenous Malformations
Neurol 55:959-964, Moussouttas,M.,et al, 2000
Cost and Outcome of Mechanical Ventilation for Life-Threatening Stroke
Stroke 31:2346-2353, Mayer,S.A.,et al, 2000
Intake of Flavonoids, Carotenoids,Vitamins C and E, and Risk of Stroke in Male Smokers
Stroke 31:2301-2306, Hirvonen,T.,et al, 2000
Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications
Stroke 31:2407-2413, De Castro,S.,et al, 2000
Chorea Resulting From Paraneoplastic Striatal Encephalitis
JNNP 69:512-515, Tani,T.,et al, 2000
Neurologic Manifestations of Infective Endocarditis
Arch Int Med 160:2781-2787, Heiro,M.,et al, 2000
Dilated Stomach and Weak Muscles
Lancet 356:1898, Rigby,S.P.,et al, 2000
Cardiac Arrhythmias and Stroke
Stroke 31:2925-2929, Engstrom,G.,et al, 2000
Familial Occipital Calcifications, hemorrhagic Strokes, Leukoencephalopathy, Dementia, and External Carotid Dysplasia
Neurol 55:1661-1667, Iglesias,S.,et al, 2000
Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids
NEJM 343:1833-1838,1886, Haller,C.A. & Benowitz,N.L., 2000
Phenylpropanolamine and the Risk of Hemorrhagic Stroke
NEJM 343:1826-1832,1886, Kernan,W.N.,et al, 2000
An Overview of Acute Stroke Therapy
Arch Int Med 160:3196-3206, Fisher,M. & Schaebitz,W., 2000
Short-term Prognosis After Emergency Department Diagnosis of TIA
JAMA 284:2901-2906, Johnston,S.C.,et al, 2000
Stroke and Pregnancy
Stroke 31:2948-2951, Jaigobin,C. & Silver,F.L., 2000
Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
Stroke 31:2920-2924, Chapman,K.M.,et al, 2000
Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke
Stroke 31:3067-3078, Bushnell,C.D. & Goldstein,L.B., 2000
Combined Perfusion- and Diffusion-Weighted MR Imagng in Acute Ischemic Stroke Durng the 1st Week: A Longitudinal Study
Radiology 217:886-894, Karnoen,J.O.,et al, 2000
Corpus Callosum Infarcts with Atypical Clinical and Radiologic Presentations
AJNR 21:1876-1880, Kasow,D.L.,et al, 2000
Protein C Deficiency Related to Valproic Acid Therapy: A Possible Association with Childhood Stroke
J Pediatr 137:714-718, Gruppo,R.,et al, 2000
Prevention of Ischaemic Stroke
BMJ 321:1455-1459, Gubitz,G. & Sandercock,P., 2000
North Carolina Stroke Prevention and Treatment Facilities Survey
Stroke 31:66-70, Goldstein,L.B.,et al, 2000
Stroke Prevention
Neurol 54:1899-1906, Holloway,R.G.,et al, 2000
Validity and Reliability of a Quantitative Computed Tomography Score in Predicting Outcome of Hyperacute Stroke Before Thrombolytic Therapy
Lancet 355:1670-1674, Barber,P.A.,et al, 2000
Safe Feeding Methods in Stroke Patients
Lancet 355:1662-1663, Finestone,H.M., 2000
Intracerebral Haemorrhage in Young Adults: The Emerging Importance of Drug Misuse
BMJ 320:1322-1324, McEvoy,A.W.,et al, 2000
Can Readmission After Stroke Be Prevented?
Stroke 31:1038-1045, Andersen,H.E.,et al, 2000
Intravenous Ancrod for Treatment of Acute ischemic Stroke
JAMA 283:2395-2403, Sherman,D.G.,et al, 2000
Ancrod-Is Snake Venom an Antidote for Stroke
JAMA 283:2440-2441, Mayberg,M.R.&Furlan,A., 2000